Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...
In The Lancet in 1971, Julian Tudor Hart gave medicine one of its most important insights: the availability of medical care ...
Richard Socher's new $650 million startup wants to build an AI that can research and improve itself indefinitely — and he ...
Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...
A $650M bet on selfimproving AI signals that a transformative, unsettling era is already underway. For decades, the idea of an artificial intelligence that designs, critiques, and rebuilds itself has ...
Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Hosted on MSN
Static network baselines won't survive agentic AI
Enterprise networks are entering a new phase in how AI is applied, moving beyond analytics dashboards and retrospective insights toward systems that recommend actions, optimize behavior, and operate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results